CN101850018A - Chinese medicine for treating cervical spondylosis - Google Patents

Chinese medicine for treating cervical spondylosis Download PDF

Info

Publication number
CN101850018A
CN101850018A CN200910236177A CN200910236177A CN101850018A CN 101850018 A CN101850018 A CN 101850018A CN 200910236177 A CN200910236177 A CN 200910236177A CN 200910236177 A CN200910236177 A CN 200910236177A CN 101850018 A CN101850018 A CN 101850018A
Authority
CN
China
Prior art keywords
parts
chinese medicine
angelica
cervical spondylosis
chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200910236177A
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN200910236177A priority Critical patent/CN101850018A/en
Publication of CN101850018A publication Critical patent/CN101850018A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a Chinese medicament for treating cervical spondylosis, and belongs to the field of Chinese medicaments for treating orthopaedic system diseases. The Chinese medicament aims to have good effect and quick response. The Chinese medicament is prepared from raw materials such as angelica dahurica, radix rehmanniae, clematis root, Chinese angelica, radix pseudo-ginseng, manchurian wildginger, kudzuvine root, glossy ganoderma and the like. The Chinese medicament has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis, dispelling the wind and relieving muscles and eliminating cold and stopping pain, and has the advantages of obvious effect, definite curative effect and quick response.

Description

一种治疗颈椎病的中药 Chinese medicine for treating cervical spondylosis

技术领域technical field

本发明属于治疗骨科系统疾病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating orthopedic system diseases.

背景技术Background technique

目前的旨在治疗颈椎病的中药方面,存在一些突出的问题:一是效果不够明显,二是见效比较迟缓。以致于大批中老年颈椎病患者由于得不到有效药物的治疗,长年颈肩疼痛、上肢麻木,肌肉无力,严重影响了生活质量。患者及其家属对此很不满意。There are some outstanding problems in the current traditional Chinese medicine aimed at treating cervical spondylosis: the first is that the effect is not obvious enough, and the second is that the effect is relatively slow. As a result, a large number of middle-aged and elderly patients with cervical spondylosis suffer from long-term neck and shoulder pain, upper limb numbness, and muscle weakness due to lack of effective drug treatment, which seriously affects the quality of life. Patients and their families are not satisfied with this.

针对以上提出的问题,本发明提供一种治疗颈椎病的中药,它能解决以往此类中药治疗中效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。In view of the problems raised above, the present invention provides a traditional Chinese medicine for the treatment of cervical spondylosis, which can solve the problem that the effect of this type of traditional Chinese medicine is not obvious enough in the past, and the effect is relatively slow. The advantage of quicker results.

发明内容Contents of the invention

本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:

1、一种治疗颈椎病的中药,采用中药原料制备,配方为(按重量比):1, a kind of Chinese medicine for the treatment of cervical spondylosis, adopts Chinese medicine raw material to prepare, and formula is (by weight):

白芷3——20份    生地4——30份    威灵仙4——30份Angelica dahurica 3——20 parts Shengdi 4——30 parts Clematis 4——30 parts

当归4——30份    三七3——20份    细辛2——15份Angelica 4——30 parts Sanqi 3——20 parts Asarum 2——15 parts

葛根4——30份    灵芝2——15份Pueraria 4——30 parts Ganoderma lucidum 2——15 parts

这种治疗颈椎病的中药是由下列方法制成的:This traditional Chinese medicine for treating cervical spondylosis is made by the following methods:

(1)按上述重量比,将白芷、生地、威灵仙、当归、细辛、葛根经常规水提取工艺提取,制成浸膏细粉;(1) According to the above weight ratio, Angelica dahurica, Shengdi, Clematis, Angelica, Asarum, Puerariae are extracted through a conventional water extraction process to make extract powder;

(2)按上述重量比,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Panax notoginseng and Ganoderma lucidum into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.

本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。方中葛根解肌散寒;威灵仙祛风散寒;合以灵芝、生地益气养血,扶正培本;当归、三七活血化瘀;白芷、细辛通络止痛。诸药配伍,相得益彰,共奏扶正培本,益气养血,活血化瘀,祛风解肌,散寒止痛之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. In the prescription, kudzu root relieves muscles and dispels cold; Clematis dispels wind and dispels cold; combined with Ganoderma lucidum and Shengdi, nourishes qi and nourishes blood, strengthens the body; Angelica and Sanqi activate blood and remove blood stasis; Angelica dahurica and Asarum relieve pain. All the medicines are compatible and complement each other. They play the functions of strengthening the body, nourishing qi and nourishing blood, promoting blood circulation and removing blood stasis, dispelling wind and relieving muscles, dispelling cold and relieving pain. The effect is good and quick. advantage.

具体实施方式Detailed ways

通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:

1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):

白芷60克    生地80克    威灵仙80克Angelica dahurica 60 grams Rehmannia 80 grams Clematis 80 grams

当归80克    三七60克    细辛40克Angelica 80g Panax notoginseng 60g Asarum 40g

葛根80克    灵芝40克Pueraria 80g Ganoderma lucidum 40g

按规定重量,用常规水提取工艺将白芷、生地、威灵仙、当归、细辛、葛根提取,制成浸膏细粉126克,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊807粒,每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, use the conventional water extraction process to extract Angelica dahurica, Shengdi, Clematis, Angelica, Asarum, and Pueraria root to make 126 grams of extract powder. The fine powder is mixed, stirred evenly, made into fine particles, packed into No. 0 capsules, and made into 807 Chinese medicine capsules, each capsule containing 0.28 grams of Chinese medicine fine powder and extract.

2、取以下配方(重量按克为单位):2. Take the following formula (weight is in grams):

白芷100克    生地160克    威灵仙160克Angelica dahurica 100g Rehmannia 160g Clematis 160g

当归160克    三七100克    细辛70克Angelica 160g Sanqi 100g Asarum 70g

葛根160克    灵芝70克Pueraria 160g Ganoderma lucidum 70g

按上述同样的方法,制成中药胶囊1475粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 1475 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):

白芷200克    生地300克    威灵仙300克Angelica dahurica 200g Rehmannia 300g Clematis 300g

当归300克    三七200克    细辛150克Angelica 300g Sanqi 200g Asarum 150g

葛根300克    灵芝150克Pueraria 300g Ganoderma lucidum 150g

按上述同样的方法,制成中药胶囊2910粒,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, 2910 Chinese medicine capsules were made, and each capsule contained Chinese medicine fine powder and 0.28 gram of extract.

4、取以下配方(按重量比):4. Take the following formula (by weight):

白芷6份    生地8份    威灵仙8份6 parts of Angelica dahurica 8 parts of raw land 8 parts of Clematis

当归8份    三七5份    细辛4份Angelica 8 parts Panax notoginseng 5 parts Asarum 4 parts

葛根8份    灵芝4份8 servings of kudzu root 4 servings of Ganoderma lucidum

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

5、取以下配方(按重量比):5. Take the following formula (by weight):

白芷15份    生地25份    威灵仙25份Angelica dahurica 15 parts Shengdi 25 parts Clematis 25 parts

当归25份    三七15份    细辛10份Angelica 25 parts Panax notoginseng 15 parts Asarum 10 parts

葛根25份    灵芝10份Pueraria root 25 parts Ganoderma lucidum 10 parts

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

临床资料:clinical information:

本发明以中医颈椎病为例,经6例临床观察。选择中医诊断颈椎病为标准:患者肢软乏力,身上没劲;颈肩疼痛、上肢麻木,常伴有头痛、头晕、耳鸣、上肢肌肉萎缩。如上症状,即可确诊。在确诊观察的对象中,男性3例,女性3例,无其它严重疾病,年龄为48岁-76岁,平均年龄62岁。The present invention takes cervical spondylosis of traditional Chinese medicine as an example, through 6 cases of clinical observation. Choose TCM diagnosis of cervical spondylosis as the standard: the patient's limbs are weak and weak, and the body is dull; neck and shoulder pain, numbness of the upper limbs, often accompanied by headache, dizziness, tinnitus, and muscle atrophy of the upper limbs. The above symptoms can be diagnosed. Among the confirmed observation objects, there were 3 males and 3 females, without other serious diseases, aged 48-76 years, with an average age of 62 years.

疗效判定:Judgment of curative effect:

1、显效:体质增强,身上有劲;颈肩疼痛、上肢麻木、肌肉无力、汗出异常明显缓解,颈部舒适。1. Significant effect: Physical fitness is enhanced, body is strong; neck and shoulder pain, upper limb numbness, muscle weakness, abnormal sweating are obviously relieved, and the neck is comfortable.

2、有效:体质增强,身上有劲;肩颈疼痛有所缓解。2. Effective: physical fitness is enhanced, body is strong; shoulder and neck pain is relieved.

3、无效:病症无变化。3. Ineffective: no change in symptoms.

临床实验时,停服其它药物和保健营养品。服用本发明中药胶囊,观察6个月,为一个疗程。服用方法:每日2次,每次4粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,1个月后症状即有缓解,服用6个月后,症状明显改善。临床实验的6人中,显效3人,有效2人,无效1人,总有效率83.3%。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 6 months, be a course of treatment. Dosing method: 2 times a day, 4 capsules each time, each capsule contains 0.28 grams of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 1 month, and after 6 months of taking, Symptoms improved significantly. Among the 6 people in the clinical trial, 3 people were markedly effective, 2 people were effective, and 1 person was ineffective, and the total effective rate was 83.3%.

Claims (1)

1.一种治疗颈椎病的中药,采用中药原料制备,配方为(按重量比):1. a kind of Chinese medicine for the treatment of cervical spondylosis, adopts Chinese medicine raw material to prepare, and formula is (by weight): 白芷3——20份    生地4——30份    威灵仙4——30份Angelica dahurica 3——20 parts Shengdi 4——30 parts Clematis 4——30 parts 当归4——30份    三七3——20份    细辛2——15份Angelica 4——30 parts Sanqi 3——20 parts Asarum 2——15 parts 葛根4——30份    灵芝2——15份Pueraria 4——30 parts Ganoderma lucidum 2——15 parts 这种治疗颈椎病的中药是由下列方法制成的:This traditional Chinese medicine for treating cervical spondylosis is made by the following methods: (1)按上述重量比,将白芷、生地、威灵仙、当归、细辛、葛根经常规水提取工艺提取,制成浸膏细粉;(1) According to the above weight ratio, Angelica dahurica, Shengdi, Clematis, Angelica, Asarum, Puerariae are extracted through a conventional water extraction process to make extract powder; (2)按上述重量比,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Panax notoginseng and Ganoderma lucidum into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.
CN200910236177A 2009-10-22 2009-10-22 Chinese medicine for treating cervical spondylosis Pending CN101850018A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200910236177A CN101850018A (en) 2009-10-22 2009-10-22 Chinese medicine for treating cervical spondylosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200910236177A CN101850018A (en) 2009-10-22 2009-10-22 Chinese medicine for treating cervical spondylosis

Publications (1)

Publication Number Publication Date
CN101850018A true CN101850018A (en) 2010-10-06

Family

ID=42801808

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200910236177A Pending CN101850018A (en) 2009-10-22 2009-10-22 Chinese medicine for treating cervical spondylosis

Country Status (1)

Country Link
CN (1) CN101850018A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103110879A (en) * 2012-12-10 2013-05-22 宋爱民 External-use traditional Chinese medicine preparation for treating torticollis
CN105267680A (en) * 2015-11-19 2016-01-27 王猛 Medicine composition for treating cervical spondylosis

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103110879A (en) * 2012-12-10 2013-05-22 宋爱民 External-use traditional Chinese medicine preparation for treating torticollis
CN103110879B (en) * 2012-12-10 2015-09-16 宋爱民 The Chinese medicine for outer use for the treatment of stiff neck
CN105267680A (en) * 2015-11-19 2016-01-27 王猛 Medicine composition for treating cervical spondylosis

Similar Documents

Publication Publication Date Title
CN101843699A (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843694A (en) Chinese medicament for treating chronic hepatitis
CN101843723B (en) Chinese medicament for treating abnormal menstruation
CN101843747B (en) Chinese medicament for treating rheumatoid arthritis
CN101843660B (en) Chinese medicament for treating tachycardia
CN101843709B (en) Chinese medicament for treating abnormal menstruation
CN101843679B (en) Chinese medicament for treating cervical spondylosis
CN101843708B (en) Chinese medicament for treating cervical spondylosis
CN101843753B (en) Chinese medicament for treating angina
CN101843731B (en) Chinese medicament for treating femoral head necrosis
CN101843759B (en) Oral Chinese medicament for treating fracture
CN101843717B (en) Chinese medicament for treating coronary disease
CN101850078B (en) Chinese medicament for treating chronic nephritis
CN101843741A (en) Chinese medicament for treating femoral head necrosis
CN101804184B (en) Traditional Chinese medicine composition for treating chest distress and preparation method thereof
CN101843799B (en) Oral Chinese medicament for treating fracture
CN101849985B (en) Chinese medicament for treating tachycardia
CN101843798B (en) Oral Chinese medicament for treating fracture
CN101843777B (en) Chinese medicament for treating liver cirrhosis
CN101850083B (en) Chinese medicament for treating asthma
CN101843750B (en) Chinese medicament for treating chronic nephritis
CN101843806B (en) Chinese medicament for treating climacteric syndromes
CN101843729A (en) Chinese medicament for treating cervical spondylosis
CN101843796A (en) Chinese medicament for treating pulmonary heart diseases
CN101843739A (en) Oral Chinese medicament for treating fracture

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20101006